Associations between angiotensin-converting enzyme inhibitors and angiotensin II receptor blocker use, gastrointestinal symptoms, and mortality among patients With COVID-19.
Abstract
No abstract availableCitation
Tan ND, Qiu Y, Xing XB, Ghosh S, Chen MH, Mao R. Associations Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality Among Patients With COVID-19. Gastroenterology. 2020 Sep;159(3):1170-1172.e1. doi: 10.1053/j.gastro.2020.05.034. Epub 2020 May 16Type
ArticleAdditional Links
http://www.sciencedirect.com/science/journal/00165085PMID
32422208Journal
GastroenterologyPublisher
W.B. Saundersae974a485f413a2113503eed53cd6c53
10.1053/j.gastro.2020.05.034